| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1001/ARCHINTERNMED.2010.39 |
| P698 | PubMed publication ID | 20421551 |
| P50 | author | Cary P Gross | Q88467914 |
| P2093 | author name string | Adam Licurse | |
| Emma Barber | |||
| Steve Joffe | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 675-682 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | The impact of disclosing financial ties in research and clinical care: a systematic review | |
| P478 | volume | 170 |
| Q38231479 | A systematic review of state and manufacturer physician payment disclosure websites: implications for implementation of the Sunshine Act. |
| Q96031526 | Bioengineering horizon scan 2020 |
| Q34062206 | Conflict of interest in clinical practice guideline development: a systematic review |
| Q39020631 | Conflicts of interest in research: looking out for number one means keeping the primary interest front and center |
| Q26863432 | Disclosing conflicts of interest in patient decision aids |
| Q41103748 | Do patients and health care professionals view the communication processes of clinical research differently? A Rasch analysis from a survey |
| Q30783958 | Effect of physician disclosure of specialty bias on patient trust and treatment choice |
| Q37791240 | Ethical considerations in clinical training, care and research in psychopharmacology |
| Q36951441 | Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study |
| Q92213794 | Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study |
| Q30613341 | Finding type 2 diabetes causal single nucleotide polymorphism combinations and functional modules from genome-wide association data |
| Q53203744 | In Response: Effectively addressing bias in risk assessment will require attention both to the nature of scientific objectivity and to public perceptions of research legitimacy--A perspective from academia. |
| Q38854764 | Is Industry Funding Associated with Greater Scholarly Impact Among Academic Neurosurgeons? |
| Q48708509 | It is time to move beyond a culture of unexamined assumptions, recrimination, and blame to one of systematic analysis and ethical dialogue |
| Q33807895 | Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research. |
| Q34403714 | Knowledge of undisclosed corporate authorship ("ghostwriting") reduces the perceived credibility of antidepressant research: a randomized vignette study with experienced nurses |
| Q36111491 | Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review |
| Q42641537 | Making transparency matter |
| Q48393391 | Managing potential conflict of interest in journal article publication |
| Q28478255 | Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review |
| Q41235768 | Methodological quality of systematic reviews referenced in clinical practice guidelines for the treatment of opioid use disorder. |
| Q60924066 | Mining Open Payments Data: Analysis of Industry Payments to Thoracic Surgeons From 2014-2016 |
| Q35964324 | Of money and trust in medical care redux |
| Q30974816 | Orthopaedic Surgeons Receive the Most Industry Payments to Physicians but Large Disparities are Seen in Sunshine Act Data |
| Q33938276 | Patient advocacy organizations: institutional conflicts of interest, trust, and trustworthiness |
| Q48048038 | Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics |
| Q36143127 | Patient views on financial relationships between surgeons and surgical device manufacturers |
| Q38818146 | Payments to Pediatricians in the Sunshine Act. |
| Q33584724 | Perceived conflict of interest in health science partnerships |
| Q42838485 | Physical activity in the UK: a unique crossroad? |
| Q38925837 | Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey. |
| Q34294990 | Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study |
| Q41996052 | Reporting of conflicts of interest in oral presentations at medical conferences: a delegate-based prospective observational study |
| Q38649519 | Should disclosure of conflicts of interest in medicine be made public? Medical students' views |
| Q38373757 | The Effects of Public Disclosure of Industry Payments to Physicians on Patient Trust: A Randomized Experiment |
| Q35214096 | The Physician Payments Sunshine Act: data evaluation regarding payments to ophthalmologists |
| Q37307255 | The relationship between the physician and pharmaceutical industry: background ethics and regulation proposals |
| Q57989604 | Transparency of Conflicts of Interest: A Mixed Blessing? The Patients' Perspective |
| Q39527166 | Two years into the Sunshine Act: synopsis of opportunities, challenges, learnings, and potential implications |
| Q38092146 | Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review |
| Q92055074 | When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest |
| Q40596702 | Where the Sun Shines: Industry's Payments to Transplant Surgeons. |
| Q87288913 | [Patient attitudes and expectations towards conflicts of interest of attending physicians] |
Search more.